Rare diseases
Investigational molecules
Locations
Back to Romania39 clinical trials in Galati, Romania across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
RomaniaEfficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
RomaniaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
RomaniaEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
RomaniaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
RomaniaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
RomaniaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
RomaniaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
RomaniaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
RomaniaStudy of Plozasiran for Adults with Severe Hypertriglyceridemia
RomaniaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
RomaniaStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 2 Diabetes and metabolic conditions, evaluating new therapeutic approaches including tirzepatide and orforglipron treatments. Studies aim to improve glycemic control and assess cardiovascular outcomes.
Multiple trials are exploring combination therapies with existing treatments like insulin glargine.
Clinical investigations centered on Systemic Lupus Erythematosus, testing novel treatments including dapirolizumab pegol and BMS-986165 to evaluate long-term safety and efficacy.
Research focuses on developing sustainable treatment options for chronic autoimmune conditions.
Comprehensive studies addressing Non-alcoholic Steatohepatitis and chronic hepatitis conditions, investigating innovative treatments including semaglutide and bepirovirsen.
Trials aim to improve liver histology and reduce disease progression.
Advanced research on obesity and related conditions, studying new therapeutic options including retatrutide for weight management and associated complications.
Studies include evaluation of treatments for obesity-related conditions like knee osteoarthritis.
Innovative research addressing Major Depressive Disorder with a focus on anhedonia, testing new adjunctive therapies like aticaprant alongside traditional antidepressants.
Studies aim to enhance treatment outcomes for patients with moderate-to-severe symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
